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Abstract
Introduction: Owing to wide availability, low cost and avoidance of ethical concerns, umbilical cord blood (UCB)
provides an attractive source of stem cells for investigational and therapeutic uses. In this study, we sought to
characterize the gene expression changes as stem cells from UCB differentiate toward alveolar type II pneumocytes
(ATII).
Methods: Control and experimental cells were cultured in maintenance medium (mesenchymal stem cell growth
medium) or differentiation medium (small airway growth medium (SAGM)), respectively, for 8 days. Total RNA was
isolated from control and experimental groups for gene expression profiling and real-time polymerase chain
reaction assay.
Results: Analysis of only mixed cell lines (n = 2) with parameters including a P value of 0.01 and an intergroup
gap of 2.0 yielded a set of 373 differentially expressed genes. Prominently upregulated genes included several
genes associated with ATII cells and also lung cancers: ALDH3A1, VDR and CHKA. Several upregulated genes have
been shown to be integral or related to ATII functioning: SGK1, HSD17B11 and LEPR. Finally, several upregulated
genes appear to play a role in lung cancers, including FDXR and GP96. Downregulated genes appear to be
associated with bone, muscle and central nervous system tissues as well as other widespread tissues.
Conclusions: To the best of our knowledge, this accounting of the gene expression changes associated with the
differentiation of a human UCB-derived stem cell toward an ATII cell represents the first such effort. Dissecting
which components of SAGM affect specific gene regulation events is warranted.
Introduction
Boyse first proposed the use of human umbilical cord
blood (UCB) for therapeutic reconstitution (Boyse EA
et al., unpublished), and later Broxmeyer et al. [1] showed
that the frequency of hematopoietic progenitor cells in
this graft source surpassed that found in bone marrow.
Researchers now commonly utilize UCB as a source of
mesenchymal stromal cells (MSCs) [2], and several investi-
gators have reported success in isolating pluripotent stem
cells [3,4]. Owing to wide availability, low cost and avoid-
ance of ethical problems, UCB provides an attractive
source of stem cells for investigational and therapeutic
uses, including cell therapy approaches to treating lung
diseases [5,6].
Recently, some of the molecular and cell biological fea-
tures important in the in vivo maintenance of lung stem
cells (bronchioalveolar stem cells) and their differentia-
tion into lung epithelium have been described [7]. Wade
et al. [8] documented the gene expression changes
engendered by treatment of cultured fetal lung epithelial
cells with dexamethasone and cyclic AMP (cAMP) dur-
ing differentiation into alveolar type II pneumocytes
(ATII) and identified a set of “hormonally responsive”
genes putatively involved in this process. Previously we
reported the differentiation of UCB-derived multilineage
progenitor cells (MLPCs) into cells which expressed
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which displayed morphologic features (visualized by light
and transmission electron microscopy) consistent with
ATII cells [9]. However, in general, the precise mechan-
isms underpinning in vitro differentiation events invol-
ving stem cells remain obscure.
A more complete understanding of these differentia-
tion processes may aid in the development of cell-based
therapeutic approaches and enhance our knowledge of
progenitor cell biology. In the current study, we report
the results of gene expression profiling performed on
our previously described, UCB-derived multipotent stem
cells, or MLPCs, differentiated in culture into cells that
express features of ATII cells [9].
Materials and methods
Cell culture
MLPCs were cultured and differentiated in small airway
growth medium (SAGM; Lonza, Walkersville, MD, USA)
as described earlier [9]. RNA was extracted from three
pairs of control (cells maintained in standard stem cell
medium) and SAGM-cultured cells using TriReagent
(Molecular Research Center, Inc., Cincinnati, OH, USA),
representing two mixed and one clonal MLPC lines.
Microarray analysis
Following the Affymetrix GeneChip Human Genome
U133A Plus 2.0 protocol (Affymetrix, Santa Clara, CA,
USA), total RNA was converted to biotin-labeled cRNA,
which was then hybridized to U133A Plus 2.0 Affyme-
trix microarray chips by the technical staff at the Uni-
versity of Minnesota Microarray Facility, a part of the
BioMedical Genomics Center [10]. All washing, staining
and scanning procedures were performed as described
in the Affymetrix protocols [11]. The U133A Plus 2.0
contained 47,000 probe sites, with multiple redundan-
cies at selected loci. A total of six hybridization events
were performed, beginning with RNA from three differ-
entiated lines and three control cell lines.
The raw fluorescence data (in Affymetrix CEL file for-
mat) containing fluorescence readings for 11 pairs of
24- to 30-bp probes with one perfect match and one
mismatched probe in each set were analyzed using
Expressionist software downloaded from the Minnesota
Supercomputing Institute website at the University of
M i n n e s o t a[ 1 2 ] .T h ed a t aw e r en o r m a l i z e df o ro v e r a l l
expression level to a median reference value of 10,000
dimensionless fluorescence units. The data from all
hybridizations had the same median fluorescence values
before normalization, and this step was unnecessary.
Differentially regulated genes were identified using the
t-test within the Expressionist software analysis package.
The microarray data were deposited into ArrayExpress
(accession number E-MEXP-3041) [13].
Statistical analysis
Genes were selected as up- or downregulated using the
t-test as described above with P values less than or
equal to 0.01 and an intergroup gap greater than or
equal to 2.0. Additional analyses of the entire expression
set were performed with P values ranging from 0.01 to
0.0001.
Database analysis
Details regarding the disease associations for each gene
of interest were gathered f r o mt h eO n l i n eM e n d e l i a n
Inheritance in Man database [14]. Assignment of mole-
cular function was derived from the Swiss-Prot database
[15].
Real-time reverse transcriptase polymerase chain reaction
assay
Total RNA was isolated and cDNA was synthesized as
described earlier [9]. Primers and probes for each gene
analyzed were obtained from Applied Biosystems (Foster
City, CA, USA). Protocols utilized standard manufac-
turer-recommended conditions for the TaqMan Gene
Expression Assay (Life Technologies, Foster City, CA,
USA) chemistry employed. Glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) was amplified as a housekeep-
ing control. The amount of target gene expression was
normalized to the expression of GAPDH and to a cali-
brator using the comparative cycle threshold (Ct)
method, 2
-ΔΔC
t, as described in detail in User Bulletin 2
for the ABI Prism 7700 Sequence Detection System
(Applied Biosystems).
Results
General gene expression profiling results
Analysis of the raw data generated from the gene expres-
sion chip hybridization showed 23,000 analyzable data
points. At P values ranging from 0.01 to 0.0001, the num-
ber of differentially expressed genes between the induced
and control groups exceeded that expected by chance by
approximately three- to sixfold (see Table 1).
Analysis of only mixed lines with parameters including
a P value of 0.01 and an intergroup gap of 2.0 yielded a
set of 373 differentially expressed genes. Analysis of the
clonal cell line yielded a similar set of genes. After
exclusion of expressed sequence tags and unknown
Table 1 Differentially expressed genes at various P
values
a
P value Differentially expressed genes Expected
0.01 845 230
0.001 71 23
0.000 12 2
aUsing Expressionist software and analyzing the mixed cell lines, the numbers
of differentially expressed genes are listed for various P values.
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108 downregulated genes. The induced genes repre-
sented a wide range of molecular functions, including
transcription regulation, DNA binding, transport, RNA
binding, signaling and housekeeping (see Table 2). Simi-
larly, the downregulated genes comprised a diverse func-
tional group and included transcription factors, DNA
binding, transport, RNA binding, signaling and house-
keeping (see Table 3). Polycomb group (PcG)-associated
genes accounted for 8 (4.9%) of 162 induced genes,
including the three most upregulated genes, and 12
(11.1%) of 108 downregulated genes.
Tables 4 and 5 show the most prominently up- and
downregulated, as well as selected, genes of interest.
Table 6 details gene chip and quantitative real-time
reverse transcriptase polymerase chain reaction (qRT-
PCR) assay data for a subset of hormonally responsive
genes described by Wade et al. [8] (see Introduction).
Discussion
To the best of our knowledge, this account of the gene
expression changes associated with the differentiation of a
human UCB-derived stem cell toward a terminally differ-
entiated respiratory epithelial cell (namely, an ATII cell)
represents the first such effort. Our control group con-
sisted of multipotential human cord blood-derived stem
cells (MLPCs) maintained in a standard mesenchymal
stem cell growth medium (MSCGM; Stem Cell Technolo-
gies, Vancouver, BC, Canada). Our experimental group
Table 2 Molecular functions of upregulated genes
a
Molecular function MLPCs (induced) Genome
Transcription regulation 15.4 10.4
Hydrolase 10.4 8.7
Unknown function 10.4
RNA binding 9.9
Protein binding 9.2
DNA binding 6.2 9.1
Transport 4.9 5.9
Signaling 4.9 21.1
Oxidoreductase 4.3 3.8
Receptor 4.3 4.7
Kinase 3.7 1.1
Transferase 3.1 8.2
Chaperone 2.5
Ion transport 2.5 1.9
Ligase 1.9
Developmental 1.2 2.8
Membrane protein 1.2
Protein synthesis 1.2
Metal binding 0.6 6.2
Nuclear anchor 0.6
Immune modulation 0.6
Protease inhibitor 0.6
aMLPC, multilineage progenitor cell. Molecular functions of genes upregulated
in small airway growth medium-induced cells, as defined in the Swiss-Prot
and TrEMBL databases, expressed as a percentage of the total upregulated
group and compared to molecular functions of all known genes in the
genome (see Wade et al. [8]).
Table 3 Molecular functions of downregulated genes as
defined in the Swiss-Prot and TrEMBL databases,
expressed as a percentage of the total downregulated
group and compared to molecular functions of all known
genes in the genome
a
Molecular function MLPCs (induced) Genome
Transcription regulator 6.5 10.4
Developmental 6.5 2.8
Receptor 6.5 4.7
Signaling 4.6 21.1
Hydrolase 4.6 8.7
Cell adhesion 4.6 0.4
Transport 4.6 5.9
Muscle differentiation-related 4.6
Unknown function 4.6
Extracellular matrix 3.7 1.4
RNA binding 3.7
Protein binding 3.7
Cytoskeletal 3.7
Oxidoreductase 2.8 3.8
GTPase 2.8 10.6
Transferase 2.8 8.2
Calcium binding 2.8 3.1
Isomerase 1.9 0.7
Chromatin regulator 1.9
Binding 1.9
Ligase 1.9
Cell junction 1.9
Metal binding 1.9 6.2
Kinase 1.9 1.1
Growth factor 0.9
Secreted 0.9
Calmodulin-binding 0.9 1
G protein exchange 0.9
Membrane protein 0.9
Cytokine 0.9
Motor protein 0.9
ATP binding 0.9 7.3
Hormone 0.9
Tumor antigen 0.9
RNA splicing 0.9
Endosomal trafficking 0.9
ATP synthesis 0.9
Ion channel 0.9 0.2
Lysase 0.9 0.9
aMLPC, multilineage progenitor cell. Molecular functions for which no genome
value is listed reflect updates in the Swiss-Prot/TrEMBL databases and author
discretion in assigning function if no clear function is listed in the above-
mentioned databases (see Wade et al. [8]).
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maintenance medium (SAGM; Stem Cell Technologies).
Few studies exist for comparison, and these groups studied
expression changes from different starting cell popula-
tions. For example, Wade et al. [8] isolated human second
trimester lung epithelial cells and differentiated these cells
in culture using various combinations of cAMP and dexa-
methasone as differentiation agents. Despite a recent
report [16] detailing surface immunophenotype similarities
between neonatal lung cells and mesenchymal stem cells,
we anticipated major differences in the gene expression
profiles between our cells: (1) human UCB-derived cells
differentiated toward ATII cells and (2) human lung cells.
Using Expressionist software to analyze the raw hybri-
dization data, three to six times the number of genes
appear to be reproducibly differentially expressed rela-
tive to what would be expected by chance. This finding
suggests that a differentiation event has taken place and
that we are not simply viewing “noise” in the system.
Similarly, the percentages of the upregulated and down-
regulated genes in each molecular function category
generally mirror the percentages of these categories
among known genes in the entire genome, with several
notable departures. In both the up- and downregulated
sets, the percentages of genes that effect signaling and
metal binding are lower than those in the genome as a
whole. In the downregulated gene group, the percentage
of genes that function in cell adhesion is higher than
that found among all genes. These data suggest that sig-
naling and metal binding functions are similar for
MLPCs and the differentiated counterpart, and therefore
are likely equivalently crucial for maintenance of both
phenotypes. The decrease in the expression of cell adhe-
sion genes in the induced cells may indicate a change in
the repertoire of possible extracellular matrix interac-
tions between the induced and control cells.
Table 4 Upregulated genes
a
Official
symbol
Name Fold
change
Significance
ALDH3A1 Aldehyde dehydrogenase 3
family member A1
13.2 Expressed in rat lung and non-small cell lung cancers. May contribute to
cyclophosphamide resistance.
FDXR Ferredoxin reductase 9.8 Higher expression levels seen in metastatic colorectal cancer than in normal controls.
GADD45B Growth arrest and DNA damage-
inducible b
7.6 Induced by differentiation-inducing cytokines.
SGK1 Serum/glucocorticoid-regulated
kinase 1
5.0 Expressed in lung, functioning in water and sodium balance. Mineralocorticoid-
responsive.
VDR Vitamin D (1,25-dihydroxyvitamin
D3) receptor
4.6 Hypothesized to play a key role in ATII maturation and surfactant synthesis.
HSP90B1 Heat shock protein 90 kDa b
(Grp94)
4.2 Increased expression seen in mesothelioma and squamous cell lung cancer.
HDS17B1 Hydroxysteroid (17b)
dehydrogenase 11
3.6 Expressed in distal bronchioles and ATII cells.
CHKA Choline kinase a 3.4 Expressed in adult rat ATII cells. Forms part of synthesis pathway for
phosphatidylcholine (pulmonary surfactant synthesis).
aATII, alveolar type II pneumocyte. Expression change (expressed as fold change relative to control cells) and significance of selected upregulated genes.
Table 5 Downregulated genes
a
Official
symbol
Name Fold
change
Significance
CTHRC1 Collagen triple-helix repeat containing 1 37.5 Inhibitor of TGF-b
INHBA Inhibin, bA 26.4 Part of TGF-b superfamily with mitogenic effects on
osteoblasts
GRB14 Growth factor receptor-bound protein 14 23.8 Negative regulator of insulin receptor signaling
SCRG1 Stimulator of chondrogenesis 1 15.6 Cartilage formation
PDE1C Phosphodiesterase 1C, calmodulin-dependent 10.8 Phosphodiesterase highly expressed in heart and brain
SRY-BOX 11 SRY (sex-determining region Y) box 11 9.1 Possible role in developing nervous system
COL4A Collagen type IV, a1 8.3 Basement membrane collagen
DOCK 10 Dedicator of cytokinesis 10 7.8 G protein exchange factor with widespread expression
PDLIM7 PDZ and LIM domain 7 7.8 Mediator of protein exchange with ubiquitous expression
CYP4V2 Cytochrome P450, family 4, subfamily V polypeptide
2
7.3 Mutated in Bietti crystalline dystrophy
CD44 CD44 molecule 2.2 Crucial for stem cell niche interactions
aTGF, transforming growth factor. Expression change (expressed as fold change relative to control cells) and significance of selected downregulated genes.
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Epigenetic modifications, such as methylation of lysine
residues on histone proteins (H3K27me3 and H3K4me3),
play a major role in differentiation and cell fate determi-
nation and are effected via the actions of the PcG pro-
teins [17]. Recent reports indicate that genes that feature
only the H3K4 mark (allowing gene expression) show
high expression and function primarily in the mainte-
nance of metabolism. A second group of genes features
both the H3K4 mark (allowing expression) and the
H3K27 mark (contributing to a repressive chromatin
state), thus creating a “bivalent state” poised for either
down- or upregulation. This latter group of genes func-
tions as regulators of development. A small percentage of
genes contain only the H3K27 mark, and the substantial
balance of genes contain neither; these latter genes are
thought to be upregulated in response to physiologic sti-
muli [18]. Comparison of our set of regulated genes with
SUZ12-associated genes (SUZ12 participates in the com-
plex responsible for creating the H3K27me3 mark; the
bulk of the genes marked in this way exist in the “bivalent
state”) [18,19] shows a greater number of SUZ12-asso-
ciated genes in the downregulated relative to the upregu-
lated set (11% versus 4.9%). This result meets expectation
that as stem cells differentiate, an increasingly select
group of genes is expressed. Further, the top three upre-
gulated genes in our set are part of the SUZ12-associated
set, suggesting the possibility that these genes are devel-
opmentally important genes that may have held dual
(activating and repressing) epigenetic marks and were
upregulated in response to the differentiating agents. It
should be noted that the lists of PcG-associated genes
were generated via analyses of human and mouse
embryonic stem cells and that such data for human cord
blood stem cells have not been thus far reported
[18,20,21].
Upregulated genes
The upregulated gene set includes three genes with
documented expression and function in ATII: SGK1,
HSD17B11 and LEPR.W e b s t e ret al. [22] found high
expression of SGK1 in the lung as well as in other tis-
sues, and other researchers [23] have demonstrated
induction of SGK1 via the actions of mineralocorticoid
receptors. ATII cells function in the lung as the primary
site for reabsorption of excess sodium, and SGK1 may
function as a regulator of this process, possibly through
phosphorylation of inducible nitric oxide synthase
[24,25]. HSD17B11,a ne n z y m ep o s s i b l yi n v o l v e di n
androgen metabolism, displays expression in fetal and
adult distal bronchioles as well as in ATII cells [26].
In a separate analysis of induced versus control cells,
which involved both mixed and clonal MLPC lines, the
induced cells expressed approximately 10 times the
mRNA for LEPR relative to controls. Leptin, produced by
adipocytes, is thought to regulate body fat via a neural
feedback mechanism. Recent work by Bergen and collea-
gues [27] demonstrates the presence of functional leptin
receptors in both adult and fetal rabbit lung and further
refines the location of expression to include acinar
epithelial cells and ATII cells. Their study also showed
that increasing concentrations of leptin resulted in
increased production of disaturated phosphatidylcholine-
a specific marker of pulmonary surfactant production.
A second set of upregulated genes includes three
genes that function in ATII cells and have also been
associated with lung cancers: ALDH3A1, VDR and
CHKA. Aldehyde dehydrogenases function in the lung
Table 6 Hormone-responsive and additional genes of interest: GeneChip and real-time PCR data
a
Official
symbol
Name qRT-PCR I/
C
GeneChip I/
C
Significance
SBP Surfactant protein B NA -0.6 Putative HR gene
LAMP3 Lysosomal associated membrane protein 3 0.03 1.0 HR
LPL Lipoprotein lipase 1.43 25.0 HR
SERPINA1 a1 antiproteinase, antitrypsin 1.7 15.0 Secreted by ATII cells; functional importance
ABCA3 ATP-binding cassette, subfamily A, member 3 7.9 100.0 Expressed in lung; functions in surfactant
production
HIF3a Hypoxia-inducible factor 3, a-subunit 7.9 60.0 HR
MAOA Monoamine oxidase A 10.0 25.0 HR
ABCA1 ATP-binding cassette, subfamily A, member 1 103.2 6.0 Expressed in lung; functions in surfactant
production
NR4A2 Nuclear receptor subfamily 4, group A, member
2
110.7 5.0 HR
ALDH1b Aldehyde dehydrogenase 1b 10,716.0 2.0 HR
GAPDH Glyceraldehyde 3-phosphate dehydrogenase 1.1 NA Housekeeping gene
aPCR, polymerase chain reaction; qRT-PCR, quantitative real-time polymerase chain reaction; I/C, ratio of induced to control cells; HR, hormone-responsive; ATII,
alveolar type II pneumocyte; NA, not applicable. GeneChip and quantitative PCR data are expressed as ratios of induced to control cells and the context (that is,
significance) of this gene.
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the environment as a breakdown product of xenobiotics
or as part of endogenous metabolism. Yoon et al. [28]
found that the expression of the specific isoform
ALDH3A1 was restricted to the lung (relative to the
liver) and that the level of expression of this gene
increased from day 1 to day 60 in Wistar Han rats.
Other recent work in humans demonstrated ALDH3A1
and ALDH1A1 expression by immunohistochemistry in
squamous cell carcinomas (SSCAs) and adenocarcino-
mas (AdenoCAs), but not in small cell lung cancer
(SCLC) [29]. This same group showed increased expres-
sion of these genes in the pneumocytes of smokers rela-
tive to nonsmokers; both proteins were expressed at
high levels in normal bronchial epithelium as well [29].
The fact that SSCAs and AdenoCAs express ALDH3A1
and ALDH1A1 takes on importance in the treatment
phase, as the presence of these enzymes has been asso-
ciated with resistance to oxazaphosphorines such as
cyclophosphamide. Muzio et al. [30] and Moreb et al.
[31] have shown in A549 cell culture models that intro-
ducing arachidonic acid or selectively knocking down
RNA expression of ALDH3A1 and/or ADLH1A1 causes
increased susceptibility to cyclophosphamide.
Vitamin D receptors (VDR)a p p e a ra r o u n dd a y s1 9t o
21 in studies of fetal rat lung [32]. Investigations of rat
lungs using electron immunogold labeling show that
VDR appears to be restricted to ATII cells. Mediated via
the downstream effects of engaged VDR, 1,25(OH)2D3
(calcitriol) plays a key role in ATII maturation and pul-
monary surfactant synthesis, the latter possibly by mod-
ulation of fructose 1,6-bisphosphatase mRNA expression
[33]. Currently, the antiproliferative and chemopreventa-
tive properties of vitamin D and metabolites are being
evaluated in the setting of various neoplasms, including
lung cancer. Calcitriol has been shown to slow lung can-
cer tumor growth and metastases in mouse models [34].
Phosphatidylcholine forms the basis for pulmonary
surfactant: adult rat ATII cells show expression of
CHKA, coding for an enzyme in the synthesis pathway
for this molecule [35]. CHKA overexpression may play a
role in cell proliferation and carcinogenesis, and recent
work suggests that high expression of this protein may
negatively impact patient prognosis in human lung can-
cers [36].
A third set of upregulated genes includes two genes
that have been associated with various cancers: FDXR
and HSP90B1. FDXR functions in the p53-dependent
apoptosis pathway. Ichikawa et al. [37] showed that in
metastatic colorectal cancer, expression of FDXR was
higher in tumors that responded to therapy with 5-
fluorouracil than in nonresponders. Adjuvant com-
pounds that cause increased expression of FDXR may be
useful in this setting. Mesothelioma and squamous cell
lung cancer cells express higher levels of HSP90B1
mRNA than matched normal controls [38,39].
Additional upregulated genes do not appear to be
related to either ATII development or function or lung
cancers. For example, GADD45B binds to nuclear hor-
mone receptors (such as the retinoic acid receptor) and
is induced by various stressors, including differentiation-
inducing cytokines [40]. The role of GADD45B expres-
sion in differentiation is currently under investigation.
In summary, the most prominently upregulated genes
include three genes (SGK1, HSD17B11 and LEPR),
which have been found in previous studies to be
expressed in ATII cells and likely contribute to the
functioning of this cell type. Three genes (ALDH3A1,
VDR and CHKA) are associated both with ATII physiol-
ogy and lung cancers. Two genes (FDXR and HSP90B1)
are associated with cancer: FDXR with colorectal cancer
and HSP90B1 with SCLC and mesothelioma. These data
corroborate our earlier findings characterizing the differ-
entiation of MLPCs to ATII-like cells [9]. Further, the
upregulation of genes that appear to be associated both
with normal lung development and/or biology (ATII
functioning) and with lung or other cancers is consistent
with growing evidence that tissue-specific stem cells
appear to underlie some lung cancers [41]. Evaluating
the role of the ingredients within SAGM in the pertur-
bations in gene expression may be helpful in advancing
our understanding of both normal lung development
(stem cell to ATII differentiation) and lung oncogenesis.
Downregulated genes
The substantially downregulated set of genes includes
genes with a mixture of putative functions. Specifically,
g e n e sa c t i v ei nb o n ef o r m a t i o n ,m u s c l ec e l la c t i v i t ya n d
central nervous system development and/or metabolism
are represented (for details, see Table 5). Of note, CD44
is downregulated in SAGM-induced cells relative to con-
trols. CD44 plays key roles in stem cell stromal interac-
tions in general. Wagner et al. [42] characterized CD44-
stromal cell interactions in CD34
+/CD38
- progenitor
cells, particularly in those culled from UCB. Understand-
ing progenitor-stromal cell interactions gains importance
when one considers that these interactions are crucial for
maintenance of “stemness” properties such as self-
renewal and asymmetrical cell division. The leukemic
stem cell likewise requires such niche interactions, and
this requirement formed the basis for the hypothesis that
altering these interactions may form the basis for antitu-
mor therapies. Jin et al. [43] showed that the use of an
anti-CD44 antibody blocked engraftment of human acute
myelogenous leukemia cells transplanted into nonobese
diabetic-severe combined immunodeficiency mice.
Further, they demonstrated drastically reduced serial
repopulation.
Berger et al. Stem Cell Research & Therapy 2011, 2:19
http://stemcellres.com/content/2/2/19
Page 6 of 8qRT-PCR hormonally responsive gene set
LPL, HIF3a, MAOA, NR4A2 and ALDH1b showed
increased expression (as determined via qRT-PCR assay)
in the induced versus control MLPCs (see Table 6).
LAMP3 showed decreased expression in the induced
versus control cells. Wade et al. [8] described a set of
genes expressed in ATII precursor cells culled from
human fetal lungs treated with various combinations of
dexamethasone and cAMP. We show upregulation of a
subset of these genes in our system, possibly indicating
a basic role for these genes in the stem cell to ATII cell
transition.
qRT-PCR for additional genes of interest
SERPINA1 (a1-antitrypsin), ABCA1 and ABCA3 showed
increased expression in our induced versus control cells
by qRT-PCR assay (see Table 6). a1-Antitrypsin is
secreted by ATII cells, functions to maintain protease
balance and further plays a key role in the pathophysiol-
ogy of emphysema. Understanding the regulation of this
gene may provide insights into emphysema treatment.
ABCA1 and ABCA3 code for ATP-binding cassette pro-
teins that transport lipids and sterols and are integral to
surfactant production. These proteins are found in the
limiting membrane of the lamellar bodies, and, further,
ABCA3 mRNA is highly expressed in the lung. The
upregulation of these genes is consistent with our
hypothesis that induced MLPCs have adopted features
of ATII cells and further adds to our understanding of
the stem cell-to-ATII cell transition.
Finally, our data may provide some of the tools used
to improve the differentiation of UCB-derived stem cells
to ATII cells. Samadikuchaksaraei and Bishop [44],
using murine embryonic stem cells, determined that a
serum-free medium, small airway basal medium (SABM;
SAGM minus all additives), stimulated the production
of SPC mRNA more robustly than SABM with single
additions of any of the numerous additives that combine
to make up SAGM. Building on this work, we think that
it may be instructive to utilize additional and alternative
end points to SPC mRNA expression as a means of
monitoring the effectiveness and completeness of a dif-
ferentiating agent such as SAGM. Our study suggests
numerous possible genes or combinations of genes the
monitoring of which may provide subtle information
regarding cell state.
ATII cells play multiple roles in distal lung processes.
Besides the formation of pulmonary surfactant and the
regulation of fluid and ionic balance, ATII cells can pro-
liferate in response to lung injury and differentiate into
alveolar type I pneumocytes to replace injured epithe-
lium. Ultimately, UCB-derived stem cells, differentiated
in vitro into ATII cells, may form the basis of a thera-
peutic approach to repair diseased or injured lung tissue.
Understanding the genetic mechanisms underpinning
UCB stem cell to ATII differentiation may play a crucial
role in the success of this effort.
Conclusions
In summary, the gene expression data described in this
article show parallels with earlier efforts and substantially
extend our knowledge of the gene expression changes
that accompany the differentiation of MSC-like UCB
cells with a hormone cocktail. We anticipate further
refinement of these processes, such as may be gathered
via culture of our MLPCs in selected elements found
within SAGM, serial time points and various alternative
culture strategies (for example, Matrigel (BD Biosciences,
Franklin Lakes, NJ, USA) and air fluid interface).
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